Supplies pharmaceutical products to pharmacies, clinics and hospitals through an online wholesale platform, and sells medicines and health products to consumers through online retail pharmacies.
20-F for FY2025, filed Apr 30, 2026
Individual consumers and pharmacy customers pay for medicines and health products when delivery is made. Pharmaceutical companies pay for services as the company provides them over time.
20-F for FY2025, filed Apr 30, 2026The Group recognizes revenues from the sale of medicines, healthcare products and other wellness merchandise through its online platforms…View ↗
Under both B2C Business and B2B Business, revenues from product sales are recognized at the point in time when the delivery is made and…View ↗
As disclosed in Note 2(l), the Group recognizes product revenue at the point in time when the delivery is made and when title and risk of…View ↗
Leveraging our direct reach to many touchpoints of the healthcare and pharmaceutical value chain, we launched our marketing and channel…View ↗
CNY 12.6B
20-F for FY2025, filed Apr 30, 2026
CNY 12.6B ↗| Segment | Share | Revenue |
|---|---|---|
|
B2C segment
|
1.8%
FY2022: 3.0%
|
B2C segment, FY2025
CNY 223.2M Sources
|
|
B2B segment
|
98%
FY2022: 96%
|
B2B segment, FY2025
CNY 12.2B Sources
|
|
MP Service
|
0.5%
FY2022: 0.5%
|
MP Service, FY2025
CNY 56.7M Sources
|
|
Other Services
|
0.2%
FY2022: 0.3%
|
Other Services, FY2025
CNY 28.6M Sources
|
Individual consumers buy through the online retail pharmacy network and storefronts on e-commerce platforms. Pharmacies, clinics and hospitals source medicines through the online wholesale platform; sales staff and commission-based City Partners recruit pharmacy customers.
20-F for FY2025, filed Apr 30, 2026In 2010, our founders launched 1 Medicine Marketplace (1药网), one of the first online retail pharmacies in China. Today, we provide hundreds…View ↗
In our online direct sales model, we acquire products from suppliers and sell them directly to consumers. For this model, we need to manage…View ↗
We acquire pharmacy customers primarily through our effective on-the-ground sales operation to allow rapid expansion of our wholesale…View ↗
Flat. Revenue was CNY 12.6B in FY2025, about the same as the CNY 12.4B of FY2021.
Loading...